Sotera Health Company Surges 25% in Q2 as Broyhill Asset Management Highlights Strong Performance
Broyhill Asset Management's second-quarter investor letter for 2026 highlighted Sotera Health Company (NASDAQ:SHC) as its top-performing stock, with shares surging by 25%. The firm attributed the strong performance to better-than-expected financial results across revenue, adjusted EBITDA, and earnings per share. Management also reaffirmed guidance and noted March was one of their best months in years. The letter emphasized that Sotera Health's stock had been undervalued at 14x forward earnings compared to its closest competitor’s 20x multiple. Additionally, the Environmental Protection Agency (EPA) proposed a full repeal of the ethylene oxide standard from 2024, which could benefit the company as it is one of only two large-scale providers in this niche market. Despite Sotera Health's strong performance and growing hedge fund interest—with 43 portfolios holding SHC at quarter-end—Broyhill remains cautious about direct semiconductor exposure. The firm continues to focus on capital preservation amid volatile markets.
Tickers: $SHC
Topics: Broyhill Asset Management Sotera Health stock performance